Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thymus Neoplasms | 2 | 2023 | 277 | 1.240 |
Why?
|
Lung Neoplasms | 14 | 2023 | 13576 | 1.000 |
Why?
|
Pleural Neoplasms | 2 | 2018 | 612 | 0.840 |
Why?
|
Carcinoma, Large Cell | 1 | 2022 | 114 | 0.780 |
Why?
|
Carcinoma, Neuroendocrine | 2 | 2022 | 342 | 0.750 |
Why?
|
Lung Diseases, Interstitial | 3 | 2019 | 945 | 0.690 |
Why?
|
Carcinoma, Small Cell | 1 | 2022 | 420 | 0.690 |
Why?
|
Thyroid Neoplasms | 5 | 2018 | 2360 | 0.660 |
Why?
|
Small Cell Lung Carcinoma | 2 | 2021 | 450 | 0.610 |
Why?
|
Thymoma | 1 | 2019 | 191 | 0.590 |
Why?
|
Cytodiagnosis | 2 | 2018 | 452 | 0.570 |
Why?
|
Idiopathic Pulmonary Fibrosis | 2 | 2024 | 520 | 0.570 |
Why?
|
GPI-Linked Proteins | 1 | 2018 | 473 | 0.550 |
Why?
|
Adenocarcinoma, Follicular | 2 | 2017 | 325 | 0.540 |
Why?
|
Thyroidectomy | 4 | 2017 | 914 | 0.540 |
Why?
|
Solitary Fibrous Tumors | 2 | 2014 | 70 | 0.530 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2019 | 489 | 0.490 |
Why?
|
Pleural Effusion | 1 | 2018 | 344 | 0.490 |
Why?
|
Mesothelioma | 2 | 2018 | 811 | 0.470 |
Why?
|
Biopsy, Fine-Needle | 2 | 2017 | 1131 | 0.460 |
Why?
|
Trans-Activators | 2 | 2023 | 2855 | 0.450 |
Why?
|
Lung | 8 | 2024 | 10087 | 0.440 |
Why?
|
Intraoperative Care | 1 | 2017 | 771 | 0.430 |
Why?
|
Thyroid Nodule | 2 | 2017 | 766 | 0.410 |
Why?
|
Transcription Factors | 3 | 2023 | 12166 | 0.410 |
Why?
|
Receptors, AMPA | 1 | 2014 | 335 | 0.410 |
Why?
|
Connective Tissue Diseases | 1 | 2015 | 285 | 0.390 |
Why?
|
Thyroid Gland | 2 | 2016 | 1172 | 0.360 |
Why?
|
Patient Care Management | 1 | 2013 | 304 | 0.350 |
Why?
|
Lung Diseases | 2 | 2023 | 1925 | 0.340 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2019 | 2911 | 0.320 |
Why?
|
Repressor Proteins | 1 | 2020 | 2986 | 0.320 |
Why?
|
Immunohistochemistry | 7 | 2018 | 11117 | 0.290 |
Why?
|
Diagnosis, Differential | 8 | 2020 | 13019 | 0.270 |
Why?
|
Terminology as Topic | 1 | 2013 | 1539 | 0.260 |
Why?
|
Pulmonary Embolism | 1 | 2019 | 2587 | 0.240 |
Why?
|
Leukemia Inhibitory Factor | 1 | 2024 | 81 | 0.240 |
Why?
|
Adenocarcinoma, Mucinous | 2 | 2017 | 526 | 0.200 |
Why?
|
Interleukin-13 | 1 | 2024 | 391 | 0.200 |
Why?
|
Receptor, Notch2 | 1 | 2021 | 90 | 0.190 |
Why?
|
Carcinoma | 1 | 2013 | 2340 | 0.190 |
Why?
|
Observer Variation | 2 | 2018 | 2623 | 0.190 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2021 | 161 | 0.180 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2023 | 207 | 0.180 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2024 | 637 | 0.180 |
Why?
|
Carcinoma, Papillary | 2 | 2018 | 793 | 0.170 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 5422 | 0.170 |
Why?
|
Hong Kong | 1 | 2019 | 168 | 0.170 |
Why?
|
Smoking | 1 | 2016 | 9109 | 0.160 |
Why?
|
Synovial Membrane | 1 | 2022 | 535 | 0.160 |
Why?
|
Pulmonary Alveolar Proteinosis | 1 | 2019 | 41 | 0.160 |
Why?
|
Metaplasia | 1 | 2019 | 326 | 0.160 |
Why?
|
Receptor, Notch1 | 1 | 2021 | 520 | 0.150 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 53 | 0.150 |
Why?
|
Thoracic Neoplasms | 1 | 2020 | 269 | 0.140 |
Why?
|
Carcinoma, Papillary, Follicular | 1 | 2018 | 59 | 0.140 |
Why?
|
Humans | 35 | 2024 | 768298 | 0.140 |
Why?
|
Fibroblasts | 2 | 2024 | 4175 | 0.140 |
Why?
|
Chromogranins | 1 | 2017 | 160 | 0.140 |
Why?
|
Gene Fusion | 1 | 2019 | 356 | 0.140 |
Why?
|
Middle Aged | 14 | 2020 | 223463 | 0.130 |
Why?
|
Aged | 13 | 2020 | 171544 | 0.130 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2017 | 195 | 0.130 |
Why?
|
Sensitivity and Specificity | 3 | 2020 | 14736 | 0.120 |
Why?
|
Soft Tissue Neoplasms | 2 | 2014 | 1166 | 0.120 |
Why?
|
Aged, 80 and over | 7 | 2020 | 59683 | 0.120 |
Why?
|
Tomography, X-Ray Computed | 3 | 2019 | 20766 | 0.120 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2018 | 281 | 0.120 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 710 | 0.110 |
Why?
|
Incidental Findings | 1 | 2019 | 697 | 0.110 |
Why?
|
Pathology, Clinical | 1 | 2017 | 376 | 0.110 |
Why?
|
STAT6 Transcription Factor | 1 | 2013 | 196 | 0.110 |
Why?
|
Killer Cells, Natural | 1 | 2022 | 2207 | 0.110 |
Why?
|
Male | 14 | 2020 | 364870 | 0.100 |
Why?
|
Immunotherapy, Adoptive | 1 | 2022 | 1508 | 0.100 |
Why?
|
Workflow | 1 | 2017 | 859 | 0.100 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2019 | 799 | 0.100 |
Why?
|
Immunity, Humoral | 1 | 2016 | 611 | 0.100 |
Why?
|
Proteomics | 2 | 2023 | 3906 | 0.100 |
Why?
|
Adult | 11 | 2020 | 223622 | 0.100 |
Why?
|
Female | 14 | 2020 | 397050 | 0.090 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2015 | 330 | 0.090 |
Why?
|
Endometrial Neoplasms | 1 | 2020 | 1382 | 0.090 |
Why?
|
Microarray Analysis | 1 | 2014 | 753 | 0.090 |
Why?
|
Dyspnea | 1 | 2019 | 1351 | 0.090 |
Why?
|
DNA, Neoplasm | 1 | 2016 | 1748 | 0.090 |
Why?
|
Immunity, Cellular | 1 | 2016 | 1561 | 0.090 |
Why?
|
Young Adult | 6 | 2017 | 60048 | 0.090 |
Why?
|
Cell Nucleus | 2 | 2016 | 2887 | 0.090 |
Why?
|
Retrospective Studies | 6 | 2023 | 81768 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4647 | 0.080 |
Why?
|
Biopsy | 3 | 2019 | 6808 | 0.080 |
Why?
|
DNA Mutational Analysis | 4 | 2020 | 4120 | 0.080 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2016 | 957 | 0.080 |
Why?
|
Boston | 2 | 2019 | 9371 | 0.080 |
Why?
|
Adenocarcinoma | 2 | 2017 | 6404 | 0.080 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 3242 | 0.080 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1765 | 0.070 |
Why?
|
Lung Transplantation | 1 | 2016 | 1309 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6541 | 0.070 |
Why?
|
Receptors, Retinoic Acid | 1 | 2007 | 229 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 1 | 2022 | 3776 | 0.070 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2019 | 2256 | 0.070 |
Why?
|
DNA-Binding Proteins | 1 | 2023 | 9618 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2022 | 7885 | 0.060 |
Why?
|
Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2024 | 30 | 0.060 |
Why?
|
Lymphatic Metastasis | 1 | 2013 | 2924 | 0.060 |
Why?
|
Epidermis | 1 | 2007 | 539 | 0.060 |
Why?
|
Tretinoin | 1 | 2007 | 524 | 0.060 |
Why?
|
Graft Rejection | 1 | 2016 | 4505 | 0.050 |
Why?
|
Myofibroblasts | 1 | 2024 | 229 | 0.050 |
Why?
|
Disease Management | 1 | 2013 | 2536 | 0.050 |
Why?
|
Keratinocytes | 1 | 2007 | 876 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 12557 | 0.050 |
Why?
|
Signal Transduction | 2 | 2024 | 23629 | 0.050 |
Why?
|
Neoplasm Metastasis | 1 | 2013 | 4921 | 0.050 |
Why?
|
Janus Kinase 2 | 1 | 2024 | 561 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2016 | 5802 | 0.050 |
Why?
|
Interleukin-4 | 1 | 2024 | 1157 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9433 | 0.040 |
Why?
|
Age Factors | 1 | 2017 | 18472 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15455 | 0.040 |
Why?
|
Recurrence | 1 | 2013 | 8501 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2019 | 18047 | 0.040 |
Why?
|
Multiple Endocrine Neoplasia Type 2a | 1 | 2019 | 40 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2017 | 22292 | 0.040 |
Why?
|
Bronchoalveolar Lavage | 1 | 2019 | 131 | 0.040 |
Why?
|
Transfection | 2 | 2021 | 5758 | 0.040 |
Why?
|
Cell Line, Tumor | 3 | 2022 | 17132 | 0.040 |
Why?
|
Cohort Studies | 3 | 2018 | 41791 | 0.040 |
Why?
|
Mutation | 3 | 2017 | 30230 | 0.040 |
Why?
|
Adolescent | 2 | 2017 | 89182 | 0.040 |
Why?
|
Adrenalectomy | 1 | 2019 | 348 | 0.030 |
Why?
|
Stromal Cells | 1 | 2022 | 1337 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2013 | 7453 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5857 | 0.030 |
Why?
|
Risk Factors | 2 | 2013 | 74954 | 0.030 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2019 | 892 | 0.030 |
Why?
|
Pathology, Surgical | 1 | 2016 | 150 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2016 | 39405 | 0.030 |
Why?
|
Cough | 1 | 2019 | 599 | 0.030 |
Why?
|
Societies, Medical | 2 | 2017 | 3960 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2023 | 2568 | 0.030 |
Why?
|
Cystectomy | 1 | 2019 | 645 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2023 | 18358 | 0.030 |
Why?
|
Genes, ras | 1 | 2016 | 665 | 0.030 |
Why?
|
Bronchoscopy | 1 | 2019 | 913 | 0.030 |
Why?
|
Hospitals, Teaching | 1 | 2016 | 1155 | 0.020 |
Why?
|
Prostatectomy | 1 | 2019 | 1841 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1280 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2015 | 21163 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2016 | 3631 | 0.020 |
Why?
|
Mice | 3 | 2023 | 82004 | 0.020 |
Why?
|
Animals | 4 | 2023 | 169322 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2013 | 2524 | 0.020 |
Why?
|
Pneumonia | 1 | 2019 | 2162 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2007 | 317 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2013 | 65365 | 0.020 |
Why?
|
Keratins | 1 | 2007 | 502 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3666 | 0.020 |
Why?
|
Child | 1 | 2013 | 80894 | 0.020 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2007 | 423 | 0.010 |
Why?
|
Radiography | 1 | 2015 | 6993 | 0.010 |
Why?
|
Phenotype | 1 | 2022 | 16716 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10863 | 0.010 |
Why?
|
Ultrasonography | 1 | 2015 | 6001 | 0.010 |
Why?
|
Cattle | 1 | 2007 | 3827 | 0.010 |
Why?
|
Prospective Studies | 2 | 2016 | 54921 | 0.010 |
Why?
|
Down-Regulation | 1 | 2007 | 2937 | 0.010 |
Why?
|
Up-Regulation | 1 | 2007 | 4137 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2007 | 5800 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2007 | 9563 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2007 | 12801 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2007 | 10464 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2007 | 11914 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2007 | 22355 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2007 | 13696 | 0.000 |
Why?
|
Concepts
(177)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(77)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_